Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 614-503-3 | CAS number: 68441-62-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP compliant near -guideline study, no restrictions, fully adequate for assessment.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 985
- Report date:
- 1985
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- 2-Butyne-1,4-diol, polymer with 2-(chloromethyl)oxirane, brominated, dehydrochlorinated, methoxylated
- EC Number:
- 614-503-3
- Cas Number:
- 68441-62-3
- Molecular formula:
- (C3H7O2)xC4H4O2Br2(C4H9O2)y with x + y = 2.5
- IUPAC Name:
- 2-Butyne-1,4-diol, polymer with 2-(chloromethyl)oxirane, brominated, dehydrochlorinated, methoxylated
- Reference substance name:
- Triethyl phosphate
- EC Number:
- 201-114-5
- EC Name:
- Triethyl phosphate
- Cas Number:
- 78-40-0
- Molecular formula:
- C6H15O4P
- IUPAC Name:
- triethyl phosphate
- Test material form:
- liquid: viscous
- Details on test material:
- - Name of test material (as cited in study report): B251, suspensions in 1% tragacanth mucilage.
- Lot/batch No.: Batch No. 1106
- Physical state: liquid
- Analytical purity: not specified
Constituent 1
Constituent 2
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: TNO, Zeist, the Netherlands
- Age at study initiation: not specified
- Weight at study initiation: 180-200 g at arrival
- Fasting period before study: 16 hours prior to dosing until 6 hours post-dosing
- Housing: five per cage
- Diet: free access
- Water: ad libitum
- Acclimation period: 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 20-23
- Humidity (%): 60-70
- Air changes (per hr): not specified
- Photoperiod (hrs dark / hrs light): 12 / 12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- The test material was given by stomach tube. The dose volume was 10 ml/kg.
- Doses:
- 625, 1250, 2500 and 5000 mg/kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- no
- Details on study design:
- Clinical signs:
Rats were observed at about 0, 0.5, 1.5, 3, 6, 24 and 48 hours after dosing and thereafter on each day until the end of the experiment. Any sign of intoxicification during the 14 days observation period was recorded.
Body weight:
The rats were weighted one day before and at 2, 7 and 14 days after dosing.
Autopsy:
Gross post-mortem examination was made on all rats that died during the observation period. At the end of the experiment, the rats were killed by ether inhalation and autopsied. All the groups were examined. - Statistics:
- LD50 and 95% confidence limits were calculated according to the method of Weil (1952): Biometrics 8: 249:263.
Results and discussion
Effect levels
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 1 337 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 862 - 2 070
- Mortality:
- 625 mg/kg bw: no mortalities;
1250 mg/kg bw: 3/5 died;
2500 mg/kg bw: 4/5 died (two between 6 and 24 hours, and two between 24 and 48 hours after dosing);
5000 mg/kg bw: 5/5 died (one between 1.5 and 3 hours, two between 3 and 6 hours and two between 6 and 24 hours). - Clinical signs:
- other: no signs were observed in control and animals treated with 625 mg/kg bw; for 1250 mg/kg bw moderate to severe signs (mostly) with onset between 6 and 24 hours after dosing were as for 2 500 mg/kg bw except that twitches, diminished righting reflex and sa
- Gross pathology:
- Autopsy of the rats that died as a result of treatment revealed effects on the gastro-intestinal tract (irritation), kidneys (pale), liver (pale), lymph nodes (congested) and lungs (red spots).
One surviving rat of the 2500 mg/kg bw group had a slightly enlarged liver and slight irritation of the fundus. The other surviving rats had no effects.
Applicant's summary and conclusion
- Interpretation of results:
- Category 4 based on GHS criteria
- Conclusions:
- The LD50 of Polyol IXOL B251 was 1337 mg/kg bw.
- Executive summary:
The acute oral toxicity of Polyol IXOL B251 was investigated in a GLP compliant study using a protocol similar to OECD guideline 401 (Duphar B.V., 1985a). Single doses of B251 in 1%-tragacanth were given by stomach tube to groups of five male fasted rats. The doses were 6 25, 1250, 2500 and 5000 mg/kg bw. The animalswere weighed one day before and at 2, 7 and 14 days after dosing. Any toxic sign occurring during the 14-day observation period was recorded. Gross post-mortem examination was done on dead animals and on the survivorsat the end of the 14-day observation period.
At 625 mg/kg bw, no mortalities were observed; at 1250 mg/kg bw, 3/5 animals died; at 2500 mg/kg bw: 4/5 animals died and 5000 mg/kg bw: 5/5 animals died. The LD50 was 1337 mg/kg bw. There was a dose-related weight loss in the first days after dosing. Thereafter there was a recovery. The signs were mainly indicative of an effect on the autonomic nervous system (hypothermia, ptosis, diminished respiratory rate, pilo-erection, lacrimation), on the central nervous system (apathy, twitches, diminished alertness and startle response, positional passivity, decreased grooming), on motor coordination (loss of righting reflex, diminished locomotor activity, abnormal gait) and on muscle tone (diminished body tone and limb tone). Autopsy of the rats that died as a result of treatment revealed effects on the gastro-intestinal tract (irritation), kidneys (pale), liver (pale), lymph nodes (congested) and lungs (red spots).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.